Jeff Auxier

Jeff Auxier

Last Update: 11-09-2017

Number of Stocks: 152
Number of New Stocks: 6

Total Value: $492 Mil
Q/Q Turnover: 3%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Jeff Auxier past Portfolios

Jeff Auxier 13F Filings

Portfolio DateNumber of StocksTotal Value (Mil)Number of New StocksQ/Q Turnover
2017-09-30160$49263%
2017-06-30157$49001%
2017-03-31160$47772%
2016-12-31157$46032%
2016-09-30154$44772%
2016-06-30152$43792%
2016-03-31150$42241%
2015-12-31147$44182%
2015-09-30147$42823%
2015-06-30151$47952%
2015-03-31147$49512%
2014-12-31152$50141%
2014-09-30156$48021%
2014-06-30160$48963%
2014-03-31156$46962%
2013-12-31152$47673%
2013-09-30146$43223%
2013-06-30148$41463%
2013-03-31146$40257%
2012-12-31147$34537%
2012-09-30150$33274%
2012-06-30149$31788%
2012-03-31140$311109%
2011-12-31134$26278%
2011-09-30136$21845%
2011-06-30133$25266%
2011-03-31130$24078%
2010-12-31124$2102648%
2010-09-3099$10255%
2010-06-30103$9112%
2010-03-31102$9554%

Jeff Auxier 13D/G Filings

Filing date :

Jeff Auxier Watch

  • Jeff Auxier Comments on Discovery

    John Malone is the largest shareholder and is on record with the intention of consolidating the media "content" space. This can act as a positive catalyst for Discovery (NASDAQ:DISCA) which is a leader in European sports programing in addition to the US. We have been happy shareholders of John Malone for years. The stock trades for 11 times forward earnings.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Molson

    Molson (NYSE:TAP) is a beer brand that has endured over 150 years. They recently made a good buy on Miller which greatly enhances their distribution in the US. Despite being a leading player in craft beer, there is a plethora of brewers which has led to a correction in TAP’s share price. Free cash flow is over $1 billion.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Kroger

    Kroger (NYSE:KR) is the leading grocer in the US. The price of groceries has declined for 18 consecutive months which represents one of the longest declines in over 50 years. Egg prices are down over 60% in the past three years. Eating at home is a tremendous bargain compared to eating out. New competitors like Amazon/Whole Foods and foreign entrants Aldi and Lidl have added to the negative sentiment. Kroger has competed very well with Walmart for several years now. Kroger is a fierce competitor and after visiting several stores in three states we are convinced they offer compelling food value and strong execution. At 11 times depressed earnings it looks too cheap.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Johnson & Johnson

    AAA rated Johnson & Johnson (NYSE:JNJ) is the world’s largest medical conglomerate. Johnson & Johnson just completed the acquisition of Actelion which gives them a sixth therapeutic area to address potential patients with pulmonary arterial hypertension. Johnson & Johnson expects the acquisition of Actelion to add $1.3 billion in sales for 2017.




    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on America Movil

    Controlled by the Slim family of Mexico, America Movil (NYSE:AMX) has been "hopelessly out of favor" as they are the number one telecom player in Latin America and have suffered with currencies and increased competition. However, they are good operators and showed an 18.5% increase in revenue for the quarter. They are adding 4.5G which is expected to be 7.5 times faster than 4G. The Slim family has several generations of cumulative business experience in many of the markets they serve.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Mastercard

    Mastercard (NYSE:MA) delivered net revenue gains of 12% as the labor markets continued to improve domestically and global retail spending improved as well. Mastercard is investing $170 million towards their E-wallet service Masterpass and partnering with PayPal Holdings to boost their mobile payment initiatives. Mastercard has delivered exceptional returns since our purchase at $22.14, compared to the current market of $128.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Bank of New York

    Bank of New York (NYSE:BK) recently added an exceptional CEO in Charles Scharf who helped lead Visa in technology and international expansion. The company is benefitting from the relaxation in capital requirements and higher short-term interest rates. They are returning $4 billion to shareholders while raising the dividend 26% to $0.24.



    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Medtronic

    Deeply oversold in 2016 political uncertainties, the world's largest standalone medical technology company rebounded sharply for the quarter. A leader in biomedical devices, they sold their medical supplies business for $6.1 billion and will pay down debt and repurchase shares.


    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on UnitedHealth

    UnitedHealth (NYSE:UNH) has continued to execute since our original purchase of $46. The stock today is over $185. The company, through the heavy use of data analytics, has dominated a relatively dull industry. United’s market capitalization has continued to grow double digits every year for the last decade. The dividend was recently increased 20% to $0.75.


    From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.   


  • Jeff Auxier's Summer 2017 Market Commentary

    Summer 2017 Market Commentary

      


  • Jeff Auxier Comments on Bank of New York

    Banks in general declined off euphoric post-election highs although Bank of New York (NYSE:BK) still sells at a significant discount to the market and will benefit greatly if interest rates normalize.

    After a difficult global earnings and revenue environment for over six quarters, we are seeing a pickup in sales and earnings for our core positions as many economies have seemed to stabilize. Domestically, the ISM services index still shows good improvement over 55%. We work hard at monitoring fundamentals to be able to catch the turn. While we are concerned with making good buys, it is also important to monitor highly valued “high expectation” stocks that can suffer painful drops when results fall short. We are looking for high integrity, dynamic management teams that can build value in any environment. We have learned over the years that having the cumulative knowledge of specific businesses, cash flows and balance sheets is far more important than being a market operator. When focusing on the power of compounding, it is critical to quantify and constantly assess risk through an in-depth knowledge of facts and valuation with a focus on the growth in underlying per share intrinsic value. At the core of mitigating risk is understanding the asset and the fundamentals. The problem with the proliferation of exchange traded funds is that nobody truly understands what they own as individual businesses. Most are following momentum. The real value added comes when markets drop and you really need to know the individual fundamentals at the height of panic. Many of the top Fund positions we have owned for 20-30 years. We want to be prepared daily and know ahead of time what we want to own. Then when the market drops we are ready to act. I love to study great coaches and in particular legendary UCLA basketball coach John Wooden who had preached that “the will to win is not nearly as important as the will to prepare to win.” We see the will to grind out daily research as integral to prepare for difficult times and improve the odds of protecting our clients’ life savings.




    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Visa

    Visa (NYSE:V) dominates the global market for electronic payments handling over half of all credit card transactions globally. The trend toward digital payments and away from cash is strong and fundamentals for global commerce and spending have been improving. Their network processes over $8 trillion in transactions annually.



    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Cerner

    Cerner (NASDAQ:CERN) is a leading healthcare information technology company which provides critical software to help automate hospitals and other healthcare providers. The stock traded down to a multiyear low valuation at year end providing for an attractive entry point to this high-quality enterprise.



    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Anthem

    Anthem (NYSE:ANTM) is a leading managed care operator which operates under the Blue Cross/Blue Shield brand. Fourth quarter net income was up 103% year over year as medical enrollment increased 3.4%. They are expecting their operating cash flow to be greater than $3.5B in 2017.


    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Oracle

    Oracle (NYSE:ORCL)’s cloud revenue growth continues to expand reaching $1.2B in the most recent quarter, a growth of 62% year over year. Oracle is selling more enterprise SaaS than any cloud services provider in the world, and claims their new Gen2 IaaS is both faster and lower cost than Amazon web services.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Corning

    Corning (NYSE:GLW) is engaged in the manufacturing of specialty glass. They expect their gas particulate filters to become a significant business in China following the finalization of emission-related regulations in December 2016. Corning recently made a deal to provide Gorilla Glass for moderately priced smartphones that are within the reach of many of India’s customers—the second largest smartphone market in the world.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Philip Morris

    Philip Morris (NYSE:PM) is working on transforming from a cigarette company to focusing on meeting the growing demand of reduced risk, smoke-free tobacco products. They estimate that about 1.4 million adults quit smoking cigarettes in 2016 and switched to their IQOS product that heats tobacco rather than burns it, and annual production capacity will grow from 7 billion units to more than 32 billion units in 2017.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on PepsiCo

    PepsiCo (NASDAQ:PEP) was the single largest contributor to US retail food and beverage growth in 2016 for the third straight year. They also announced their 45th consecutive annualized dividend increase in 2017 and are driving 3.7% organic revenue growth through healthier products.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Zimmer Biomet Holdings

    Zimmer Biomet (NYSE:ZBH) has a leading musculoskeletal portfolio and is the global market share leader in knees and hips. Zimmer is also predicting $2B in annual free cash flow by 2020. At year end the stock traded down to a steep discount to the market, an attractive 12 times earnings. The demographics favor hips and knees as the peak year is age 68—about the average age for baby boomers. According to the Pew Research Center, roughly 10,000 Americans turn 65 every day. Pain is a good motivator for action.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


  • Jeff Auxier Comments on Medtronic plc

    Medtronic is a leader in implantable biomedical devices. Back in 2001 the stock traded at 37.5 times earnings and this past quarter traded down to 13 times earnings with a fortress balance sheet and a 7% free cash flow yield. They continue to be a leader in medical technology as their world’s smallest pacemaker, Micra, accelerates US sales driving pacemaker market growth. They generate over $5 billion in free cash flow annually.

    From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.   


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK